The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.

Me, the embattled Bay Area genetic testing company, permanently closed its San Francisco office and warned 250 employees of possible layoffs as part of ongoing restructuring efforts following its Chapter 11 bankruptcy filing this year.

Regeneron Pharmaceuticals is acquiring the assets of 23andMe for $256 million, excluding its Lemonaid Health business, as the company faces layoffs and office closure due to financial struggles and a past cyberattack.

Hey New Jerseyands, claims are now open for 23andMe's settlement over a data breach — and payouts may be as high as $10,000. Here's what to know.

Me, the Bay Area genetic testing company that once soared in popularity but filed for bankruptcy this year, is warning that layoffs may be imminent.

Genetic testing firm 23andMe must pay customers after personal information was exposed in a cybersecurity incident, if they submit claims by July 14.

Me is facing large-scale layoffs and potential bankruptcy, with possible closure of its San Francisco office and uncertain future for employees, including executives and scientists, amid financial struggles and a prior cyberattack.